Skip to main content

ProShares Trust II

For the period ended Dec 31, 2023. Filed Feb 28, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 28, 2024

SCO$20.19+2.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

ProShares Short VIX Short-Term Futures ETF

December 31, 2023December 31, 2022
Assets
Short-term U.S. government and agency obligations (Note 3) (cost $109,391,681 and $144,283,581, respectively)$109,410,342$144,307,676
Cash54,492,2356,852,395
Segregated cash balances with brokers for futures contracts88,647,616127,094,546
Receivable on open futures contracts30,330,66567,086,947
Interest receivable456,930475,930
Total assets283,337,788345,817,494
Liabilities and shareholders’ equity
Liabilities
Payable for capital shares redeemed15,522,3165,861,814
Payable on open futures contracts372,680—
Brokerage commissions and futures account fees payable9,57121,576
Payable to Sponsor248,862342,466
Total liabilities16,153,4296,225,856
Commitments and Contingencies (Note 2)
Shareholders’ equity
Shareholders’ equity267,184,359339,591,638
Total liabilities and shareholders’ equity$283,337,788$345,817,494
Shares outstanding2,584,3075,784,307
Net asset value per share$103.39$58.71
Market value per share (Note 2)$103.40$58.68

F-

Principal AmountValue
Short-term U.S. government and agency obligations
(41% of shareholders’ equity)
U.S. Treasury Bills^^:
5.442% due 01/18/24$25,000,000$24,941,223
5.345% due 02/01/2450,000,00049,780,000
5.417% due 02/20/2415,000,00014,892,507
5.382% due 03/12/2420,000,00019,796,612
Total short-term U.S. government and agency obligations (cost $109,391,681)$109,410,342
Futures Contracts Sold
Number of ContractsNotional Amount at ValueUnrealized Appreciation (Depreciation)/Value
VIX Futures - Cboe, expires January 20245,412$76,045,095$10,168,009
VIX Futures - Cboe, expires February 20243,77857,786,0212,472,615
$12,640,624
^^Rates shown represent discount rate at the time of purchase.

F-

Principal AmountValue
Short-term U.S. government and agency obligations
(42% of shareholders’ equity)
U.S. Treasury Bills^^:
3.807% due 01/03/23$50,000,000$49,995,780
4.037% due 02/07/2320,000,00019,923,876
4.268% due 02/23/2325,000,00024,849,655
4.258% due 03/09/2325,000,00024,808,837
4.401% due 04/04/2325,000,00024,729,528
Total short-term U.S. government and agency obligations (cost $144,283,581)$144,307,676
Number of ContractsNotional Amount at ValueUnrealized Appreciation (Depreciation)/Value
VIX Futures - Cboe, expires January 20234,215$97,358,492$10,597,402
VIX Futures - Cboe, expires February 20232,95172,433,180494,979
$11,092,381
^^Rates shown represent discount rate at the time of purchase.

F-

Year Ended December 31,
202320222021
Investment Income
Interest$10,251,068$3,512,477$101,467
Expenses
Management fee2,500,5603,901,7844,358,107
Brokerage commissions543,461663,288848,956
Futures account fees—381,0851,036,798
Non-recurring fees and expenses—16,339—
Total expenses3,044,0214,962,4966,243,861
Net investment income (loss)7,207,047(1,450,019)(6,142,394)
Realized and unrealized gain (loss) on investment activity
Net realized gain (loss) on
Futures contracts160,516,55321,454,600194,879,700
Short-term U.S. government and agency obligations(21,847)(86,512)118,624
Net realized gain (loss)160,494,70621,368,088194,998,324
Change in net unrealized appreciation (depreciation) on
Futures contracts1,548,243(20,182,897)22,926,495
Short-term U.S. government and agency obligations(5,434)59,620(36,437)
Change in net unrealized appreciation (depreciation)1,542,809(20,123,277)22,890,058
Net realized and unrealized gain (loss)162,037,5151,244,811217,888,382
Net income (loss)$169,244,562$(205,208)$211,745,988

F-

Year Ended December 31,
202320222021
Shareholders’ equity, beginning of period$339,591,638$423,812,594$409,371,468
Addition of 4,100,000, 7,150,000 and 5,100,000 shares, respectively282,356,336366,101,636242,419,979
Redemption of 7,300,000, 8,250,000 and 8,100,000 shares, respectively(524,008,177)(450,117,384)(439,724,841)
Net addition (redemption) of (3,200,000), (1,100,000) and (3,000,000) shares, respectively(241,651,841)(84,015,748)(197,304,862)
Net investment income (loss)7,207,047(1,450,019)(6,142,394)
Net realized gain (loss)160,494,70621,368,088194,998,324
Change in net unrealized appreciation (depreciation)1,542,809(20,123,277)22,890,058
Net income (loss)169,244,562(205,208)211,745,988
Shareholders’ equity, end of period$267,184,359$339,591,638$423,812,594

F-

Year Ended December 31,
202320222021
Cash flow from operating activities
Net income (loss)$169,244,562$(205,208)$211,745,988
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Purchases of short-term U.S. government and agency obligations(756,847,632)(1,562,961,162)(619,782,627)
Proceeds from sales or maturities of short-term U.S. government and agency obligations796,473,4421,567,832,801542,110,382
Net amortization and accretion on short-term U.S. government and agency obligations(4,755,757)(1,390,488)(61,648)
Net realized (gain) loss on investments21,84786,512(118,624)
Change in unrealized (appreciation) depreciation on investments5,434(59,620)36,437
Decrease (Increase) in receivable on open futures contracts36,756,28232,457,391(25,317,513)
Decrease (Increase) in interest receivable19,000(473,062)1,516
Increase (Decrease) in payable to Sponsor(93,604)10,5935,307
Increase (Decrease) in brokerage commissions and futures account fees payable(12,005)(82,736)(10,210)
Increase (Decrease) in payable on open futures contracts372,680—(996,159)
Increase (Decrease) in non-recurring fees and expenses payable——(1,353)
Net cash provided by (used in) operating activities241,184,24935,215,021107,611,496
Cash flow from financing activities
Proceeds from addition of shares282,356,336366,101,636242,419,979
Payment on shares redeemed(514,347,675)(450,380,700)(433,599,711)
Net cash provided by (used in) financing activities(231,991,339)(84,279,064)(191,179,732)
Net increase (decrease) in cash9,192,910(49,064,043)(83,568,236)
Cash, beginning of period133,946,941183,010,984266,579,220
Cash, end of period$143,139,851$133,946,941$183,010,984

F-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.